Bristol-Myers Squibb (BMY) Tops Q2 EPS by 14c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Bristol-Myers Squibb Reports Second Quarter Financial Results
July 26, 2018 6:59 AM EDTIncreases Second Quarter Revenues 11% to $5.7 Billion Posts Second Quarter GAAP EPS of $0.23 and Non-GAAP EPS of $1.01 Achieves Significant Regulatory Milestones in Oncology Presents Important New Data on Immuno-Oncology Portfolio at ASCO Updates 2018 GAAP and Non-GAAP EPS Guidance
NEW YORK--(BUSINESS WIRE)--... More
